Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded
In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale
NCI Study Finds No Greater Cancer Risk Near Nuclear Plants
NCI Should Examine Alternative Therapies TA Report Says
NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









